The present study aimed to evaluate the influence of omega‐3 fatty acids supplementation on the serum levels of brain‐derived neurotrophic factor (BDNF), high‐sensitivity C‐reactive protein (hs‐CRP), physical activity, and chronic fatigue in patients with multiple sclerosis (MS). This evidence concerns the gene MAP3K14 and multiple sclerosis.